Key statistics
On Tuesday, Innoviva Inc (HVE:DUS) closed at 18.00, -6.25% below its 52-week high of 19.20, set on Nov 17, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 17.90 |
|---|---|
| High | 18.00 |
| Low | 17.90 |
| Bid | -- |
| Offer | -- |
| Previous close | 17.70 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 74.77m |
| Free float | 74.01m |
| P/E (TTM) | 16.76 |
| Market cap | 1.62bn USD |
| EPS (TTM) | 1.29 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 18:31 GMT.
More ▼
Press releases
- U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
- Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea
- Innoviva to Participate in the 37th Annual Piper Sandler Healthcare Conference
